World's Highest-Multiplex POC System with RNA Quantitating Ability Detects Bacterial Infection

By HospiMedica International staff writers
Posted on 20 Nov 2023

Image: The TriVerity Acute Infection and Sepsis Test System (Photo courtesy of Inflammatix)

Sepsis and antimicrobial resistance (AMR) are major contributors to increasing deaths and healthcare costs globally. In clinical settings, diagnosing and treating these conditions present significant challenges. Physicians, especially in emergency rooms, often face difficulties in making prompt, accurate decisions regarding antibiotic use for the roughly 15 million patients annually who present with suspected acute infection and sepsis. In response to this challenge, a new test system specifically designed for emergency department use is being developed. This system aims to evaluate the likelihood of bacterial or viral infections and the risk of acute decompensation, which necessitates ICU-level care, in patients with suspected acute infection and sepsis.

Inflammatix, Inc. (Sunnyvale, CA, USA) has completed technical development for its TriVerity Acute Infection and Sepsis Test System. This system includes the Myrna Instrument and the TriVerity Cartridge. The Myrna Instrument is adept at analyzing up to 64 messenger RNAs (mRNAs) from whole blood or other types of samples within approximately 30 minutes. Designed for potential use at the point-of-care, the Myrna Instrument is aimed to meet the criteria for Clinical Laboratory Improvement Amendments (CLIA) waiver. The accompanying disposable cartridges are designed to be stable at room temperature for up to a year.

The TriVerity Acute Infection and Sepsis Test, a leading product from Inflammatix, utilizes a panel of 29 mRNAs to interpret the body's immune response, assisting in the diagnosis of patients with suspected acute infection and sepsis. This test is particularly targeted at diagnosing patients who present with suspected infections in U.S. emergency departments. Inflammatix is actively working on completing its clinical studies, including the SEPSIS-SHIELD study, which is essential for the submission of the TriVerity Test system to the U.S. Food and Drug Administration (FDA). This multi-center study has already enrolled 955 patients out of the anticipated 1,500. Inflammatix anticipates the completion of the study and the subsequent FDA submission by spring 2024.

"Myrna will be the world's highest-multiplex point-of-care system capable of quantitating RNA, allowing us to bring 'precision medicine' into acute care settings," said Dr. Timothy Sweeney, CEO and co-founder of Inflammatix. "Completing technical development brings TriVerity a step closer to FDA submission and launch, and enables us to execute key clinical studies."

"With the completion of the test system, we look forward to further exploring partnerships that bring existing RNA signatures onto the Myrna ecosystem," Dr. Sweeney commented. "This may be an especially viable pathway given expected changes to the regulation of lab-developed tests and the increased reliance on a biomarker-driven approach to immunotherapy development."

Related Links:
Inflammatix, Inc.

Visit expo >

Gold Member

Neonatal Heel Incision Device

Tenderfoot

Gold Member

SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test

SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Hybrid Arch Device

Neo EDE

Vessel Sealing Instrument

ERGOseal

Latest Critical Care News

Channels

Artificial Intelligence

view channel

Critical Care

view channel

Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines

Detecting nocturnal and morning hypertension often requires out-of-office assessment, but conventional cuff-type monitors can disrupt sleep. New national guidance in South Korea expands 24-hour monitoring... Read more

image: Principles of SMEAR-ULM. (Lai, Y., Argüello, A.N., Liu, M. et al., Nature Sensors (2026). DOI: 10.1038/s44460-026-00078-4)

“Intelligent Tattoo” Method Detects Early Melanoma Signals

Melanoma is a lethal skin cancer in which earlier detection drives better outcomes. Current evaluation relies on visual inspection followed by biopsy, which can miss nascent lesions and lead to unnecessary... Read more

Image: Reusable catheter patients used 35 percent fewer antibiotics compared to their single-use only counterparts. (Photo courtesy of the University of Southampton)

Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections

Intermittent self-catheterization, used to empty the bladder several times a day, can leave patients vulnerable to recurrent urinary tract infections and repeated antibiotic use. Reliance on single-use... Read more

Implantable Wireless Light Device Advances Bladder Cancer Treatment

Bladder cancer, a malignancy of the urinary bladder, often requires local therapies that spare surrounding tissue. Photodynamic therapy uses light-activated drugs but is limited by poor light penetration... Read more

Surgical Techniques

view channel

$Image: Catherine Duclos places an EEG electrode array on a participant\'s head (Photo courtesy of Alex Tran)$

Pink Noise Stimulation Approach Could Support Safer Anesthesia

Maintaining stable unconsciousness during general anesthesia while minimizing drug exposure remains a core perioperative challenge. Sudden nociceptive surges can disrupt anesthetic depth, increasing neurological... Read more

Surgical Robotic System Gains CE Mark for Minimally Invasive Procedures

Cornerstone Robotics’ (CSR; Hong Kong, China) Sentire Endoscopic Surgical System (Sentire Surgical System) has received European Union CE mark certification under the Medical Device Regulation (MDR) for... Read more

$Image: Avvio Medical\'s technology combines microbubble-enhanced acoustic cavitation with smart catheter navigation to precisely target and break down ureteral stones, all without the need for routine stenting or general anesthesia (Photo courtesy of Avvio Medical)$